UnitedHealth Group Incorporated with ticker code (UNH) have now 24 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between $680.00 and $568.01 with the average target price sitting at $623.61. Given that the stocks previous close was at $576.31 this is indicating there is a potential upside of 8.2%. Also worth taking note is the 50 day moving average now sits at $578.51 and the 200 moving average now moves to $521.63. The market capitalization for the company is 530.79B. The stock price is currently at: $574.81 USD
The potential market cap would be $574,353,880,047 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 38.02, revenue per share of $417.59 and a 7.07% return on assets.
UnitedHealth Group Incorporated is a diversified health care company that operates Optum and UnitedHealthcare platforms. Its segments include Optum Health, Optum Insight, Optum Rx and UnitedHealthcare. Optum Health segment is focused on care delivery, care management, wellness and consumer engagement, and health financial services. Optum Insight segment serves the needs of hospital systems, physicians, health plans, governments and life sciences companies. Optum Rx segment offers pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, purchasing and clinical capabilities, and develops programs in areas such as step therapy, formulary management, drug adherence and disease/drug therapy management. UnitedHealthcare includes the combined results of operations of UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State and UnitedHealthcare Global.
